Northern Trust’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5K | Hold |
11,921
| – | – | ﹤0.01% | 4403 |
|
|
2026
Q1 | $12K | Hold |
11,921
| – | – | ﹤0.01% | 4370 |
|
|
2025
Q4 | $11.7K | Hold |
11,921
| – | – | ﹤0.01% | 4427 |
|
|
2025
Q3 | $14.9K | Hold |
11,921
| – | – | ﹤0.01% | 4394 |
|
|
2025
Q2 | $17.8K | Hold |
11,921
| – | – | ﹤0.01% | 4345 |
|
|
2025
Q1 | $16.9K | Sell |
11,921
-250
| -2% | -$467 | ﹤0.01% | 4353 |
|
|
2024
Q4 | $24.6K | Hold |
12,171
| – | – | ﹤0.01% | 4359 |
|
|
2024
Q3 | $21.4K | Hold |
12,171
| – | – | ﹤0.01% | 4328 |
|
|
2024
Q2 | $28.4K | Sell |
12,171
-36
| -0.3% | -$70 | ﹤0.01% | 4292 |
|
|
2024
Q1 | $17.1K | Hold |
12,207
| – | – | ﹤0.01% | 4352 |
|
|
2023
Q4 | $21K | Hold |
12,207
| – | – | ﹤0.01% | 4358 |
|
|
2023
Q3 | $22.8K | Hold |
12,207
| – | – | ﹤0.01% | 4310 |
|
|
2023
Q2 | $29.2K | Hold |
12,207
| – | – | ﹤0.01% | 4335 |
|
|
2023
Q1 | $24.3K | Hold |
12,207
| – | – | ﹤0.01% | 4411 |
|
|
2022
Q4 | $23.8K | Buy |
12,207
+251
| +2% | +$643 | ﹤0.01% | 4457 |
|
|
2022
Q3 | $42K | Hold |
11,956
| – | – | ﹤0.01% | 4369 |
|
|
2022
Q2 | $59K | Hold |
11,956
| – | – | ﹤0.01% | 4357 |
|
|
2022
Q1 | $79K | Hold |
11,956
| – | – | ﹤0.01% | 4420 |
|
|
2021
Q4 | $93K | Hold |
11,956
| – | – | ﹤0.01% | 4445 |
|
|
2021
Q3 | $151K | Hold |
11,956
| – | – | ﹤0.01% | 4274 |
|
|
2021
Q2 | $179K | Buy |
11,956
+4,695
| +65% | +$71.4K | ﹤0.01% | 4199 |
|
|
2021
Q1 | $121K | Buy |
7,261
+514
| +8% | +$10.4K | ﹤0.01% | 4242 |
|
|
2020
Q4 | $110K | Sell |
6,747
-319
| -5% | -$4.43K | ﹤0.01% | 4093 |
|
|
2020
Q3 | $79K | Buy |
7,066
+863
| +14% | +$15.7K | ﹤0.01% | 4011 |
|
|
2020
Q2 | $113K | Buy |
6,203
+3,264
| +111% | +$40K | ﹤0.01% | 3887 |
|
|
2020
Q1 | $25K | Buy |
2,939
+1,711
| +139% | +$16.1K | ﹤0.01% | 4058 |
|
|
2019
Q4 | $7K | Hold |
1,228
| – | – | ﹤0.01% | 4208 |
|
|
2019
Q3 | $30K | Hold |
1,228
| – | – | ﹤0.01% | 4119 |
|
|
2019
Q2 | $35K | Sell |
1,228
-97
| -7% | -$2.88K | ﹤0.01% | 4123 |
|
|
2019
Q1 | $43K | Buy |
1,325
+195
| +17% | +$7.13K | ﹤0.01% | 4054 |
|
|
2018
Q4 | $49K | Buy |
1,130
+13
| +1% | +$429 | ﹤0.01% | 4053 |
|
|
2018
Q3 | $34K | Sell |
1,117
-325
| -23% | -$14.5K | ﹤0.01% | 4177 |
|
|
2018
Q2 | $63K | Buy |
+1,442
| New | +$53.5K | ﹤0.01% | 4087 |
|
Other funds holding COCP
VCM
VFT
PA
GSC
Northern Trust's COCP Position: Q2 2026 in Review
Northern Trust held its Cocrystal Pharma (COCP) position steady in Q2 2026 at 11,921 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4403.
Northern Trust first reported a position in COCP in Q2 2018 and has held it in 33 quarters since. The position peaked at $179K in Q2 2021. 19 funds tracked by Wall St. Rank hold COCP as of Q2 2026.
- Northern Trust held 11,921 shares of Cocrystal Pharma worth $12.5K as of Q2 2026.
- Northern Trust left its Cocrystal Pharma share count unchanged in Q2 2026.
- Cocrystal Pharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4403 holding.
- Northern Trust first reported a position in Cocrystal Pharma in Q2 2018 and has held it in 33 quarters since.
- Northern Trust's Cocrystal Pharma position peaked at $179K in Q2 2021.
- 19 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.